
A study reveals the feasibility and efficacy of using topical mupirocin prophylaxis to prevent infections in patients with indwelling pleural and peritoneal catheters (IPC and IPeC). The study found that mupirocin did not damage the catheters and was well tolerated by patients. Out of 48 patients with IPC or IPeC, 95.8% showed excellent compliance with scheduled doses. Six patients developed infections, highlighting the importance of preventive measures. This study opens the door for future randomized trials to confirm its effectiveness.
Like
Save
Share